CRG/UPF Proteomics Unit
CRG/UPF Proteomics Unit
The Proteomics Unit is a joint effort of the Universitat Pompeu Fabra and the Center of Genomic Regulation to create an innovative research infrastructure with a high-level of excellence and sustainability to support scientists in the biomedical field. The activities of the Proteomics Unit are focused onto the provision of high-quality proteomics services with strong added-value to the research community by i) offering state-of-the-art methods, advise and expertise to support basic and translational researchers; ii) developing new methods and techniques that keep the unit up to date and at the forefront of the proteomics field; and iii) training the community and actively disseminating proteomics science and methods.
The Proteomics Unit is part of the Spanish National Infrastructure for Omics Technologies (ICTS OmicsTech) and the European Proteomics Infrastructure Consortium (EPIC-XS, GA 823839), and it coordinates the European innovative and interdisciplinary Research and Training network PROTrEIN (GA 956148). The Proteomics Unit is also part of the "Plataforma de Recursos Biomoleculares y Bioinformáticos - ProteoRed" of the Instituto de Salud Carlos III, part of the Spanish National Health System (PT17/0019 ).
You can learn more about the unit by taking the virtual tour HERE.
State-of-the-art infrastructure to speed up protein analysis in Catalonia (30/06/2021)
The Centre for Genomic Regulation (CRG) has teamed up with several leading hospital research institutes in Catalonia to create a new state-of-the-art infrastructure for the study and analysis of proteins.
Boosting machine learning skills to speed up proteomics research (21/12/2020)
The CRG, together with ten other European partners, will start a new programme to train a new generation of researchers with the latest machine learning and data visualization skills to boost this burgeoning research field.
Mysterious ancestor finds new place in humanity's family tree (02/04/2020)
The Proteomics Unit of the Centre for Genomic Regulation (CRG) and Universitat Pompeu Fabra (UPF) has played a vital role in the analysis of an eight hundred thousand-year-old human fossil.
A new tool that makes it possible to adapt treatment for patients with cardiogenic shock has been developed (17/06/2019)
Cardiogenic shock is a possible complication of serious heart attack involving an associated mortality rate of approximately 50% of all cases
A molecular connection between nutrient availability and embryonic growth has been identified (06/03/2019)
Investigators of the CRG discover that AHCY, a nutrient metabolism sensor protein, is a direct activator of the genes involved in the proliferation of embryo stem cells
Ten million Euro for access to European proteomics facilities (14/01/2019)
The CRG takes part in a new EU consortium aimed at providing access to proteomics facilities throughout Europe and at improving proteomics technology. The European Union has awarded 10 million euro to a consortium of eighteen European research groups in the field of mass spectrometry based proteomics research throughout Europe.
New public-private initiative to develop a new therapy against aterosclerosis (27/01/2017)
The project - which has just received 700,000 euros in the Spanish 2016 Retos-Colaboracion call- is led by biotech Iproteos, based at the Parc Cientific de Barcelona, with the participation of the Biomedical Research Institute of Barcelona (IIBB- CSIC) and the Centre for Genomic Regulation (CRG).
A short jump from single-celled ancestors to animals (13/10/2016)
The first animals evolved from their single-celled ancestors around 800 million years ago, but new evidence suggests that this leap to multi-celled organisms in the tree of life may not have been quite as dramatic as scientists once assumed.
New tools for the diagnosis of multiple sclerosis in its early stages (14/01/2016)
Scientists at the Centre for Genomic Regulation (CRG) and the Vall d'Hebron Research Institute (VHIR) develop a new method for early diagnosis of the disease.
BRAND NEW: The CRG/UPF Proteomics Unit is the first European facility to get the newest tri-hibrid mass spectometer (25/06/2015)
Launched internationally last week during the 63rd Annual American Society for Mass Spectrometry Conference in Saint Louis (US), the top-class Orbitrap Fusion Lumos from Thermo Fisher Scientific hast just been installed in the CRG/UPF Proteomics Unit.
Eduard Sabidó CV
2006 Short Term Fellowship at The Scripps Research Institute, San Diego, USA.
2008 PhD in Biology at the University of Barcelona, Barcelona, Spain.
2009-2012 Postdoctoral fellow at Swiss Federal Institute of Technology of Zurich (ETHZ), Zürich, Switzerland.
2012- Head of the CRG/UPF Proteomics Core Facility at the Centre for Genomic Regulation (CRG), Barcelona, Spain.
Computational Proteomics Training European Innovative Network (PROTrEIN), project number 956148, funded by the Horizon 2020 programme of the European Union.
European Proteomics Infrastructure Consortium providing access (EPIC-XS), project number 823839, funded by the Horizon 2020 programme of the European Union.
SGR, project number 2017SGR595 funded by the “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya”.
Plataforma de recursos biomoleculares PRB3-ProteoRed, project number PT17/0019, funded by Instituto de Salud Carlos III and ERDF.
Title: CRG-ProMed - Creació i desenvolupament de la Plataforma de Proteòmica Biomèdica (Unitat CRG) per aplicacions biomèdiques i translacionals
Objective: Strenghtening of R+D institutions and setting up, consolidation and improvement of scientific and technological infrastructures
OT1. Boost research, technological development and innovation (Potenciar la investigació, el desenvolupament tecnològic i la innovació)
Project Nr.: IU16-015644
Eligible total cost: 1.186.000 €
FEDER funds: 593.000 €
Period: 01/01/2019 to 30/06/2021
This project is co-financed by the European Regional Development Funds of the European Union, in the framework of the ERDF Operative Programme of Catalonia 2014-2020.
At the beginning of 2018, the facility received funding from FEDER/Ministerio de Ciencia, Innovación y Universidades - Agencia Estatal de Investigación, for the Acquisition of an integrated system comprising a high-resolution hybrid mass-spec with three different types of mass analyzers and a chromatographic system UPLC for proteomic analysis (Original title of the project: Adquisición de un sistema integrado formado por un espectrómetro de masas híbrido de alta resolución con tres tipos de analizadores de masa y sistema cromatográfico UPLC para análisis proteómicos” / Reference EQC2018-005248-P).
Desarrollo de una terapia innovadora para el tratamiento de la ateroesclerosis mediante la inhibición de la acumulación vascular de colesterol (RTC-2016-5078-1)